Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 20 | 18 | −2 |
| Shares | 4.13M | 1.78M | −2.34M (−56.8%) |
| Value | $1.29M | $392.3K | −$902.0K (−69.7%) |
New holders (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cornerstone Wealth Management, LLC | 20,000 | $4.40K | 0.00% |
| Virtu Financial LLC | 11,809 | $3.00K | 0.00% |
| Simplex Trading, LLC | 1,293 | $0 | 0.00% |
Sold out (5)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Sabby Management, LLC | 2,140,174 | $672.2K |
| Prudential Financial Inc | 37,600 | $11.8K |
| Susquehanna International Group, LLP | 23,082 | $7.25K |
| Jane Street Group, LLC | 15,356 | $4.82K |
| UBS Group AG | 2,683 | $842 |